Literature DB >> 22705598

How I manage venous thromboembolism risk in hospitalized medical patients.

Mark Dobromirski1, Alexander T Cohen.   

Abstract

Venous thromboembolism is a significant cause of illness and death worldwide. Large bodies of evidence support the heightened risk status of hospitalized medical patients, and that prophylactic measures significantly reduce the risk of thrombosis, yet these patients often fail to receive adequate prophylactic therapy. This failure may be accounted for by a lack of awareness of the relevant indications, poorly designed implementation systems, and clinical concerns over the side effects of anticoagulant medications. This article briefly summarizes our understanding of the clinical factors relevant to the evaluation of venous thromboembolism risk in hospitalized medical patients. We describe our approach to the use of thromboprophylaxis, through which we aim to minimize the disease burden of this under-recognized and preventable pathology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22705598     DOI: 10.1182/blood-2012-03-378901

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

Review 1.  Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.

Authors:  Susan R Kahn; David R Morrison; Gisèle Diendéré; Alexandre Piché; Kristian B Filion; Adi J Klil-Drori; James D Douketis; Jessica Emed; André Roussin; Vicky Tagalakis; Martin Morris; William Geerts
Journal:  Cochrane Database Syst Rev       Date:  2018-04-24

2.  Effectiveness of interventions for the implementation of thromboprophylaxis in hospitalised patients at risk of venous thromboembolism: an updated abridged Cochrane systematic review and meta-analysis of randomised controlled trials.

Authors:  Susan R Kahn; Gisele Diendéré; David R Morrison; Alexandre Piché; Kristian B Filion; Adi J Klil-Drori; James Douketis; Jessica Emed; André Roussin; Vicky Tagalakis; Martin Morris; William Geerts
Journal:  BMJ Open       Date:  2019-05-24       Impact factor: 2.692

Review 3.  Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux.

Authors:  Marcello Di Nisio; Ettore Porreca
Journal:  Drug Des Devel Ther       Date:  2013-09-16       Impact factor: 4.162

4.  Venous thromboembolism prophylaxis in patients hospitalized in medical wards: A real life experience.

Authors:  Keren Mahlab-Guri; Monged Shaher Otman; Natalia Replianski; Shira Rosenberg-Bezalel; Irina Rabinovich; Zev Sthoeger
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.